King Fahd Medical City is a medical facility in Riyadh, Saudi Arabia. The complex consists of four hospitals: The Obstetrics & Gynecology Hospital, The Specialist Hospital, The Rehabilitation Hospital, and The Pediatric Hospital. It was built at a cost of $633 million.

During the past decade, King Fahad Medical City; Gastroentrology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "King Fahad Medical City; Gastroentrology" are "Rheumatoid Arthritis" (2 trials), "HER2-Positive Early Breast Cancer" (1 trials), "Hepatitis B, Chronic" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "King Fahad Medical City; Gastroentrology" in a lesser frequency.

Most popular intervention types in "King Fahad Medical City; Gastroentrology" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Paclitaxel" (1 trials) and "Pertuzumab IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Fahad Medical City; Gastroentrology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "King Fahad Medical City; Gastroentrology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in King Fahad Medical City; Gastroentrology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in King Fahad Medical City; Gastroentrology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".